Whole-exome sequencing of paired tumour/blood of 58 T1 stage bladder cancer patients
|Study ID||Alternative Stable ID||Type|
To understand the molecular determinants that underpin the clinical heterogeneity of non-muscle-invasive bladder cancer (NMIBC) we carried out whole-exome sequencing (WES) of stage T1 bladder tumours to identify prognostic biomarkers and novel therapeutic targets. The study includes paired tumour/blood samples of 58 T1 stage bladder cancer patients.
Study Datasets 1 dataset.
Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data
Tumor-blood paired whole-exome sequencing of 58 pairs of non-muscle-invasive bladder cancer samples (stageT1). Targeted sequencing of 112 non-muscle-invasive bladder cancer samples (34 stage T1; 78 stage Ta) Please note the following files have been removed: EGAR00003025153, EGAR00003025435, EGAR00003025294, EGAR00003025262, EGAR00003025224.
|Illumina HiSeq 3000||339|
Who archives the data?